ENTITY
Beijing Wantai Biological Phar

Beijing Wantai Biological Phar (603392 CH)

29
Analysis
Health CareChina
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. manufactures medical products. The Company produces enzyme linked immunodiagnostic reagents, colloidal gold rapid diagnostic reagents, vaccines, biochemical reagents, and other products. Beijing Wantai Biological Pharmacy Enterprise also produces diagnostic equipment.
more
Refresh
27 Mar 2024 18:18

Beijing Wantai Biological (603392 CH): Struggling to Make a Mark in Murky China HPV Vaccine Market

Beijing Wantai expects 70%+ decline in net profit in 2023 due to competition. Going ahead, competition is expected to intensify further in China...

Logo
288 Views
Share
26 Mar 2024 08:55

Pre-IPO Beijing Health Guard Biotechnology - The Story of the HPV Vaccine Is Not as Good as Imagined

The real China’s HPV vaccine market could be smaller-than-expected.After being included in National Immunization Program, vaccine business will be...

Logo
409 Views
Share
05 Sep 2023 08:39

Pre-IPO Wuhan YZY Biopharma - Both R&D and Commercialization Capabilities Have yet to Be Proven

YZY passed the hearing of HKEX. We've analyzed its business, pipeline and concerns in this insight. It should be pointed out that investors have...

Logo
661 Views
Share
05 Jun 2023 08:10

Northbound Flows Monthly (May): $1.7bn Outflows

We analyzed the Shanghai/Shenzhen Connect Scheme for May and highlight flows for CATL, Kunlun Tech, BJ-SH HSR, CCB, Mindray, Longi, Wuliangye,...

Logo
287 Views
Share
08 Dec 2022 08:55

Clover Biopharmaceuticals (2197.HK) Placement - A Good Bet

The commercialization of COVID-19 vaccine opens a new chapter for Clover.Share price would have big upside potential if the COVID-19 vaccine can...

Logo
489 Views
Share
x